Nirsevimab for Prevention of RSV Hospitalizations in Infants
- Talkad Raghuveer; Rosalee Zackula
Access Resources
About
This article comments on the HARMONIE trial, which concluded that nirsevimab reduced hospitalizations for respiratory syncytial virus (RSV)–associated lower respiratory tract infection in infants. The commenter discusses limitations of the trial.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.